L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
29,850
-2,450 (-7.59%)
Jul 18, 2025, 3:30 PM KST
38.52%
Market Cap734.87B
Revenue (ttm)73.32B
Net Income (ttm)139.08B
Shares Out24.62M
EPS (ttm)5,558.47
PE Ratio5.30
Forward PEn/a
Dividend50.00 (0.17%)
Ex-Dividend DateDec 27, 2024
Volume518,939
Average Volume379,497
Open31,800
Previous Close32,300
Day's Range29,850 - 31,900
52-Week Range15,000 - 33,300
Beta0.69
RSI51.16
Earnings DateAug 12, 2025

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 132
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements

News

There is no news available yet.